The Uncertain Path Forward for Psychedelic Medicine

1 year ago 47
ARTICLE AD BOX
After the FDA rejected its proposed MDMA treatment, Lykos Therapeutics is laying off 75 percent of its staff and its founder has left the company.
Read Entire Article